Pedometer-determined physical activity is linked to low systemic inflammation and low arterial stiffness in Type 2 diabetes

Diabetic Medicine

Volumn 29, Issue 9, 2012, Pages 1119-1125

  Jennersjo P ^a   Ludvigsson, J ^a   Lanne T ^a   Nystrom, F H ^a,b   Ernerudh, J ^a   Ostgren C J ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arterial stiffness; Exercise; Inflammation; Obesity; Pedometer; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; INTERLEUKIN 6; LIPID;

ABDOMINAL OBESITY; ADULT; AGED; ANTHROPOMETRY; AORTA; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CAROTID ARTERY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FEMORAL ARTERY; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE; PEDOMETER; PHYSICAL ACTIVITY; PULSE WAVE; TONOMETRY; WAIST CIRCUMFERENCE;

AGED; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; MOTOR ACTIVITY; PULSE WAVE ANALYSIS; SWEDEN; VASCULAR STIFFNESS; WALKING;

EID: 84865113002     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03621.x     Document Type: Article

References (34)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23: 105-11.
2. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-2038.
3. Thomas DE, Elliott EJ, Naughton GA. Exercise for Type 2 diabetes mellitus. Cochrane Database Syst Rev 2006; 3: CD002968.
4. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in Type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001; 286: 1218-1227.
5. Laaksonen DE, Lindström J, Lakka TA, Eriksson JG, Niskanen L, Wikström K et al. Physical activity in the prevention of Type 2 diabetes: the Finnish diabetes prevention study. Diabetes 2005; 54: 158-165.
6. Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med 1999; 340: 115-126.
7. Herder C, Peltonen M, Koenig W, Sütfels K, Lindström J, Martin S et al. Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention study. Diabetologia 2009; 52: 433-442.
8. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10-15.
9. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension Stroke 2003; 34: 1203-1206.
10. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106: 2085-2090.
11. Ford ES, Herman WH. Leisure-time physical activity patterns in the US diabetic population. Findings from the 1990 National Interview Survey - Health Promotion and Disease Prevention Supplement. Diabetes Care 1995; 18: 27-33.
12. Tudor-Locke CE, Myers AM. Challenges and opportunities for measuring physical activity in sedentary adults. Sports Med 2001; 31: 91-100.
13. Tudor-Locke CE, Myers AM. Methodological considerations for researchers and practitioners using pedometers to measure physical (ambulatory) activity. Res Q Exerc Sport 2001; 72: 1-12.
14. Yamanouchi K, Shinozaki T, Chikada K, Nishikawa T, Ito K, Shimizu S et al. Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care 1995; 18: 775-778.
15. National Survey of Public Health, Swedish National Institute for Public Health. Available at http://www.fhi.se/Documents/English/Highlights/survey-English-2007.pdf (English version) last accessed 19 March 2012.
16. Tudor-Locke C, Sisson SB, Lee SM, Craig CL, Plotnikoff RC, Bauman A. Evaluation of quality of commercial pedometers. Can J Public Health 2006; 97(Suppl 1): S10-5, S10-6.
17. Tudor-Locke C, Washington TL, Hart TL. Expected values for steps/day in special populations. Prev Med 2009; 49: 3-11.
18. Tudor-Locke CE, Bell RC, Myers AM, Harris SB, Lauzon N, Rodger NW. Pedometer-determined ambulatory activity in individuals with Type 2 diabetes. Diabetes Res Clin Pract 2002; 55: 191-199.
19. Tudor-Locke C, Basset DR Jr. How many steps/day are enough? Preliminary pedometer indices for public health. Sports Med 2004; 34: 1-8.
20. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
21. Pitsavos C, Tampourlou M, Panagiotakos DB, Skoumas Y, Chrysohoou C, Nomikos T et al. Association between low-grade systemic inflammation and Type 2 diabetes mellitus among men and women from the ATTICA study. Rev Diabet Stud 2007; 4: 98-104.
22. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 1154-1162.
23. Tudor-Locke C, Leonardi C, Johnson MD, Katzmarzyk PT, Church TS. Accelerometer steps/day translation of moderate-to-vigorous activity. Prev Med 2011; 53: 31-33.
24. Tudor-Locke C, Ainsworth BE, Whitt MC, Thompson RW, Addy CL, Jones DA. The relationship between pedometer-determined ambulatory activity and body composition variables. Int J Obes Relat Metab Disord 2001; 25: 1571-1578.
25. Iwane M, Arita M, Tomimoto S, Satari O, Matsumoto M, Myashita K, Nishio I. Walking 10, 000 steps/day or more reduces blood pressure and sympathetic nerve activity in mild essential hypertension. Hypertens Res 2000; 23: 573-580.
26. Tudor-Locke C, Johnson WD, Katzmarzyk PT. Accelerometer-determined steps per day in US adults. Med Sci Sports Exerc 2009; 41: 1384-1389.
27. Dwyer T, Ponsonby A-L, Ukoumunne OC, Pezic A, Venn A, Dunstan D et al. Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study. BMJ 2011; 342: c7249.
28. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-969.
29. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007; 27: 996-1003.
30. Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD et al. The anti-inflammatory effects of exercise training in patients with Type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 2007; 14: 837-843.
31. Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P et al. Anti-inflammatory effect of exercise training in subjects with Type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metabol Cardiovasc Dis 2010; 20: 608-617.
32. Tyo BM, Fitzhugh EC, Basset DR Jr, John D, Feito Y, Thompson DL. Effects of body mass index and step rate on pedometer error in a free-living environment. Med Sci Sports Exerc 2011; 43: 350-356.
33. Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 2003; 42: 468-473.
34. Vaitkevicius PV, Fleg JL, Engel JH, O'Connor FC, Wright JG, Lakatta LE et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993; 88: 1456-1462.